BioSig Technologies Inc. (BSGM)
NASDAQ: BSGM
· Real-Time Price · USD
1.42
0.05 (3.65%)
At close: May 05, 2025, 3:59 PM
1.28
-9.86%
Pre-market: May 06, 2025, 04:21 AM EDT
3.65% (1D)
| Bid | 1.28 |
| Market Cap | 34.44M |
| Revenue (ttm) | 40K |
| Net Income (ttm) | -10.33M |
| EPS (ttm) | -0.75 |
| PE Ratio (ttm) | -1.89 |
| Forward PE | 1.27 |
| Analyst | Buy |
| Ask | 1.46 |
| Volume | 2,615,005 |
| Avg. Volume (20D) | 334,505 |
| Open | 1.31 |
| Previous Close | 1.37 |
| Day's Range | 1.25 - 1.49 |
| 52-Week Range | 0.20 - 2.57 |
| Beta | 0.80 |
About BSGM
BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time. It also focuses ...
Industry Medical - Devices
Sector Healthcare
IPO Date Oct 31, 2014
Employees 5
Stock Exchange NASDAQ
Ticker Symbol BSGM
Website https://www.biosig.com
Analyst Forecast
According to 1 analyst ratings, the average rating for BSGM stock is "Buy." The 12-month stock price forecast is $2.5, which is an increase of 76.06% from the latest price.
Stock Forecasts5 months ago
-11.62%
BioSig Technologies shares are trading higher afte...
Unlock content with
Pro Subscription
10 months ago
-72.19%
BioSig Technologiesshares are trading lower after the company was notified by the Nasdaq Hearings Panel that its common stock will be delisted from the Nasdaq Stock Market due to non-compliance with the minimum stockholders' equity requirement.
